Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.

Farook MF, DeCuypere M, Hyland K, Takumi T, LeDoux MS, Reiter LT.

PLoS One. 2012;7(8):e43030. doi: 10.1371/journal.pone.0043030.

2.

Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Gustin RM, Bichell TJ, Bubser M, Daily J, Filonova I, Mrelashvili D, Deutch AY, Colbran RJ, Weeber EJ, Haas KF.

Neurobiol Dis. 2010 Sep;39(3):283-91. doi: 10.1016/j.nbd.2010.04.012.

3.

Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.

Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL.

PLoS One. 2010 Aug 20;5(8):e12278. doi: 10.1371/journal.pone.0012278.

4.

Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.

Mulherkar SA, Jana NR.

Neurobiol Dis. 2010 Dec;40(3):586-92. doi: 10.1016/j.nbd.2010.08.002.

PMID:
20696245
5.
6.

Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.

Grier MD, Carson RP, Lagrange AH.

Behav Brain Res. 2015 Sep 15;291:260-7. doi: 10.1016/j.bbr.2015.05.045.

7.

Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.

Mardirossian S, Rampon C, Salvert D, Fort P, Sarda N.

Exp Neurol. 2009 Dec;220(2):341-8. doi: 10.1016/j.expneurol.2009.08.035.

PMID:
19782683
8.
9.

Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism.

Ferdousy F, Bodeen W, Summers K, Doherty O, Wright O, Elsisi N, Hilliard G, O'Donnell JM, Reiter LT.

Neurobiol Dis. 2011 Mar;41(3):669-77. doi: 10.1016/j.nbd.2010.12.001.

10.

Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ.

J Clin Invest. 2012 Dec;122(12):4544-54. doi: 10.1172/JCI61888.

11.

An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.

Yi JJ, Berrios J, Newbern JM, Snider WD, Philpot BD, Hahn KM, Zylka MJ.

Cell. 2015 Aug 13;162(4):795-807. doi: 10.1016/j.cell.2015.06.045.

12.

Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.

Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH, Potluri P, Procaccio V, Acab A, Weiss JH, Wallace DC, Kimonis VE.

Neurosci Lett. 2011 Jan 7;487(2):129-33. doi: 10.1016/j.neulet.2009.06.079.

13.

Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.

Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT.

Hum Mol Genet. 2008 Jul 15;17(14):2181-9. doi: 10.1093/hmg/ddn117.

14.

Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.

Pignatelli M, Piccinin S, Molinaro G, Di Menna L, Riozzi B, Cannella M, Motolese M, Vetere G, Catania MV, Battaglia G, Nicoletti F, Nisticò R, Bruno V.

J Neurosci. 2014 Mar 26;34(13):4558-66. doi: 10.1523/JNEUROSCI.1846-13.2014.

15.

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.

Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, Eichele G, Beaudet AL.

Nat Genet. 1997 Sep;17(1):75-8.

PMID:
9288101
16.

Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.

Colas D, Wagstaff J, Fort P, Salvert D, Sarda N.

Neurobiol Dis. 2005 Nov;20(2):471-8.

PMID:
15921919
17.

Understanding the pathogenesis of Angelman syndrome through animal models.

Jana NR.

Neural Plast. 2012;2012:710943. doi: 10.1155/2012/710943. Review.

18.

Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.

Reiter LT, Seagroves TN, Bowers M, Bier E.

Hum Mol Genet. 2006 Sep 15;15(18):2825-35.

19.

Potential therapeutic approaches for Angelman syndrome.

Bi X, Sun J, Ji AX, Baudry M.

Expert Opin Ther Targets. 2016;20(5):601-13. doi: 10.1517/14728222.2016.1115837. Review.

20.

Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling.

Tamada K, Tomonaga S, Hatanaka F, Nakai N, Takao K, Miyakawa T, Nakatani J, Takumi T.

PLoS One. 2010 Dec 15;5(12):e15126. doi: 10.1371/journal.pone.0015126.

Items per page

Supplemental Content

Support Center